Insider Stock Trading History of Bozigian Haig P.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bozigian Haig P. since year 2005. The trader's CIK number is 1423837. At the time of this reporting, Bozigian Haig P. is the Chief Development Officer of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .


Stock purchases, sales, and option exercises reported by insider Bozigian Haig P. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-06 NBIX Neurocrine Biosciences Inc Option Ex 26,250 14.12 370,650
2017-09-06 NBIX Neurocrine Biosciences Inc Sale 26,250 60.00 1,575,000
2017-08-04 NBIX Neurocrine Biosciences Inc Option Ex 45,000 7.21 324,450
2017-08-04 NBIX Neurocrine Biosciences Inc Sale 22,500 50.00 1,125,000
2017-04-12 NBIX Neurocrine Biosciences Inc Sale 13,065 50.82 663,963
2017-02-06 NBIX Neurocrine Biosciences Inc Sale 963 43.14 41,543
2017-02-03 NBIX Neurocrine Biosciences Inc Sale 1,375 42.57 58,533
2017-01-17 NBIX Neurocrine Biosciences Inc Sale 1,625 40.63 66,023
2017-01-10 NBIX Neurocrine Biosciences Inc Sale 1,625 43.37 70,476
2016-02-03 NBIX Neurocrine Biosciences Inc Sale 1,375 38.13 52,428
2016-01-19 NBIX Neurocrine Biosciences Inc Sale 1,625 46.77 76,001
2016-01-11 NBIX Neurocrine Biosciences Inc Sale 1,625 44.25 71,906
2015-10-16 NBIX Neurocrine Biosciences Inc Sale 25,000 47.78 1,194,500
2015-01-16 NBIX Neurocrine Biosciences Inc Sale 1,625 30.79 50,033
2015-01-12 NBIX Neurocrine Biosciences Inc Sale 1,625 28.45 46,231
2015-01-08 NBIX Neurocrine Biosciences Inc Sale 30,000 27.30 819,150
2015-01-08 NBIX Neurocrine Biosciences Inc Option Ex 30,000 2.59 77,700
2015-01-05 NBIX Neurocrine Biosciences Inc Sale 2,500 22.76 56,900
2015-01-05 NBIX Neurocrine Biosciences Inc Option Ex 2,500 5.12 12,800
2014-12-17 NBIX Neurocrine Biosciences Inc Option Ex 15,002 2.59 38,855
2014-12-17 NBIX Neurocrine Biosciences Inc Sale 15,002 22.51 337,695
2014-12-12 NBIX Neurocrine Biosciences Inc Option Ex 9,998 3.85 38,542
2014-12-12 NBIX Neurocrine Biosciences Inc Sale 9,998 22.50 224,955
2014-12-15 NBIX Neurocrine Biosciences Inc Option Ex 2,500 5.12 12,800
2014-12-15 NBIX Neurocrine Biosciences Inc Sale 2,500 21.72 54,300
2014-01-17 NBIX Neurocrine Biosciences Inc Option Ex 25,000 3.85 96,375
2014-01-17 NBIX Neurocrine Biosciences Inc Sale 25,000 20.00 500,000
2014-01-10 NBIX Neurocrine Biosciences Inc Sale 1,625 18.58 30,192
2014-01-07 NBIX Neurocrine Biosciences Inc Sale 25,000 17.50 437,500
2013-08-21 NBIX Neurocrine Biosciences Inc Sale 13,999 15.04 210,544
2013-08-05 NBIX Neurocrine Biosciences Inc Sale 11,001 15.00 165,015
2013-06-27 NBIX Neurocrine Biosciences Inc Sale 8,000 13.00 104,000
2013-06-24 NBIX Neurocrine Biosciences Inc Sale 769 12.72 9,781
2013-06-21 NBIX Neurocrine Biosciences Inc Sale 23,962 12.73 304,964
2013-06-20 NBIX Neurocrine Biosciences Inc Sale 20,769 12.43 258,054
2011-02-28 NBIX Neurocrine Biosciences Inc Sale 12,320 6.83 84,084
2010-03-01 NBIX Neurocrine Biosciences Inc Sale 14,090 2.53 35,591
2010-01-04 NBIX Neurocrine Biosciences Inc Sale 751 2.64 1,982
2009-09-28 NBIX Neurocrine Biosciences Inc Sale 3,642 3.11 11,337
2009-03-30 NBIX Neurocrine Biosciences Inc Sale 12,774 3.43 43,776
2009-01-05 NBIX Neurocrine Biosciences Inc Sale 733 3.40 2,488
2008-09-29 NBIX Neurocrine Biosciences Inc Sale 3,618 4.70 16,986
2008-02-05 NBIX Neurocrine Biosciences Inc Sale 722 5.30 3,830

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bozigian Haig P. (Chief Development Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.